These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 660478)

  • 1. Comparative pharmacokinetics of coumarin anticoagulants XXXV: Examination of possible pharmacokinetic interaction between (R)-(+)- and (S)-(--)-warfarin in humans.
    Levy G; O'Reilly RA; Wingard LB
    J Pharm Sci; 1978 Jun; 67(6):867-8. PubMed ID: 660478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.
    Wingard LB; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1978 Feb; 23(2):212-7. PubMed ID: 620483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1980 Jan; 69(1):14-20. PubMed ID: 7354432
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.
    Yacobi A; Wingard LB; Levy G
    J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.
    Chan E; McLachlan A; O'Reilly R; Rowland M
    Clin Pharmacol Ther; 1994 Sep; 56(3):286-94. PubMed ID: 7924124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.
    Toon S; Hopkins KJ; Garstang FM; Rowland M
    Eur J Clin Pharmacol; 1987; 32(2):165-72. PubMed ID: 3582481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of coumarin anticoagulants XXXVI: Predicted steady-state patterns of prothrombin complex activity produced by equieffective doses of (R)-(+)- and (S)-(-)-warfarin in humans.
    Wingard LB; Levy G
    J Pharm Sci; 1977 Dec; 66(12):1790-1. PubMed ID: 925953
    [No Abstract]   [Full Text] [Related]  

  • 10. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of coumarin anticoagulants XXIX: Elimination kinetics and anticoagulant activity of (S)-(-)-warfarin in rats before and after chronic administration.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1275-7. PubMed ID: 903865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin.
    Kwan D; Bartle WR; Walker SE
    J Clin Pharmacol; 1999 Jan; 39(1):68-75. PubMed ID: 9987702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
    Zhou Q; Chan E
    Eur J Pharm Sci; 2002 Oct; 17(1-2):73-80. PubMed ID: 12356422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of R andS warfarin enantiomers.
    Hignite C; Uetrecht J; Tschanz C; Azarnoff D
    Clin Pharmacol Ther; 1980 Jul; 28(1):99-105. PubMed ID: 7389260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.
    Uno T; Sugimoto K; Sugawara K; Tateishi T
    Ther Drug Monit; 2008 Jun; 30(3):276-81. PubMed ID: 18520598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic interaction between disulfiram and separated enantiomorphs of racemic warfarin.
    O'Reilly RA
    Clin Pharmacol Ther; 1981 Mar; 29(3):332-6. PubMed ID: 7471603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.
    Uno T; Sugimoto K; Sugawara K; Tateishi T
    J Clin Pharm Ther; 2008 Feb; 33(1):67-73. PubMed ID: 18211619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.